Royal Bank Of Canada Pro Phase Labs, Inc. Transaction History

Royal Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.18 - $7.35 $627 - $1,102	150 Added 3000.0%	155 $0
Q1 2024 Nov 05, 2024	SELL	$4.47 - $6.47 $670 - $970	-150 Reduced 96.77%	5 $0
Q1 2024 May 15, 2024	SELL	$4.47 - $6.47 $518 - $750	-116 Reduced 95.87%	5 $0
Q4 2023 Feb 14, 2024	SELL	$4.35 - $5.1 $1,561 - $1,830	-359 Reduced 74.79%	121 $0
Q3 2023 Nov 14, 2023	SELL	$4.23 - $7.53 $43,992 - $78,312	-10,400 Reduced 95.59%	480 $2,000
Q2 2023 Aug 14, 2023	BUY	$7.15 - $9.78 $74,360 - $101,712	10,400 Added 2166.67%	10,880 $78,000
Q1 2023 May 15, 2023	SELL	$6.62 - $9.57 $57,594 - $83,259	-8,700 Reduced 94.77%	480 $3,000
Q4 2022 Feb 14, 2023	BUY	$8.78 - $12.47 $76,386 - $108,489	8,700 Added 1812.5%	9,180 $88,000
Q3 2022 Nov 14, 2022	SELL	$8.96 - $14.7 $179 - $294	-20 Reduced 4.0%	480 $5,000
Q4 2021 Feb 14, 2022	BUY	$5.13 - $7.89 $2,565 - $3,945	500 New	500 $4,000

1.91M

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $7.37M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.